Blood inhibitory capacity toward exogenous plasmin

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 3, 2007, Pages 241-246

  Banbula, Agnieszka ^a   Zimmerman, Thomas P ^a   Novokhatny, Valery V ^a  

^a Talecris Biotherapeutics Inc   (United States)

Author keywords

2 macroglobulin; 2 antiplasmin; Inhibition; Plasma; Plasmin; Thrombolysis

Indexed keywords

ALPHA 2 ANTIPLASMIN; ALPHA 2 MACROGLOBULIN; PLASMIN;

ARTICLE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; INCUBATION TIME; NORMAL HUMAN; PRIORITY JOURNAL; TEMPERATURE;

ALPHA-MACROGLOBULINS; ANTIPLASMIN; BLOOD CELLS; HUMANS; PLASMA; PLASMIN;

EID: 34247132703     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32808738b4     Document Type: Article

References (26)

1. Novokhatny VV, Taylor KK, Zimmerman TP. Thrombolytic potency of acidstabilized plasmin: superiority over tissue-type plasminogen activator in an in vitro model of peripheral arterial occlusion. J Thromb Haemost 2003; 1:1034-1041.
2. Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Thromb Haemost 1993; 69:141-146.
3. Wiman B, Collen D. On the kinetics of the reaction between human antiplasmin and plasmin. Eur J Biochem 1978; 84:573-582.
4. 2-macroglobulin, and antithrombin III in the presence of heparin. Thromb Res 1990; 59:449-462.
5. 2-macroglobulin: effect of antifibrinolytic agents. Biochemistry 1987; 26:8487-8495.
6. Marder VJ, Landskroner K, Novokhatny V, Zimmerman TP, Kong M, Kanouse JJ, et al. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit. Thromb Haemost 2001; 86:739-745.
7. Stewart D, Kong M, Novokhatny V, Jesmok G, Marder VJ. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage. Blood 2003; 101:3002-3007.
8. 1 proteinase inhibitor using zinc chelate chromatography. Anal Biochem 1979; 99:415-420.
9. Wiman B. Affinity-chromatographic purification of human alpha 2-antiplasmin. Biochem J 1980; 191:229-232.
10. 2-terminal lysine heavy (A) chain. J Biol Chem 1975; 250:4044-4047.
11. Lucas MA, Fretto LJ, McKee PA. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 1983; 258:4249-4256.
12. 2- plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 1976; 251:5956-5965.
13. 2-antiplasmin as a model inhibitor. Biochemistry 1991; 30:979-986.
14. 2- macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. J Clin Invest 1981; 68:46-55.
15. 2- macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J 1973; 133:709-724.
16. Telesforo P, Semeraro N, Verstraete M, Collen D. The inhibition of plasmin by antithrombin III-heparin complex in vitro in human plasma and during streptokinase therapy in man. Thromb Res 1975; 7:669-676.
17. Harpel PC, Cooper NR. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J Clin Invest 1975; 55:593-604.
18. Novokhatny VV, Jesmok GJ, Landskroner KA, Marder VJ, Zimmerman TP. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis? Trends Pharmacol Sci 2004; 25:72-75.
19. Bang NU, Mattler LE. Sensitivity and specificity of plasma serine protease chromogenic substrates. Haemostasis 1978; 7:98-104.
20. Kolodziej SJ, Klueppelberg HU, Nolasco N, Ehses W, Strickland DK, Stoops JK. Three-dimensional structure of the human plasmin alpha2-macroglobulin complex. J Struct Biol 1998; 123:124-133.
21. 2-macroglobulin-enzyme complexes. J Clin Invest 1973; 52:2175-2184.
22. 2-Macroglobulin. Methods Enzymol 1981; 80 (Pt C):737-754.
23. Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W, et al. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996; 35:266-272.
24. Fitzpatrick SL, Kassam G, Choi KS, Kang HM, Fogg DK, Waisman DM. Regulation of plasmin activity by annexin II tetramer. Biochemistry 2000; 39:1021-1028.
25. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of α-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30:1682-1691.
26. Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL, et al. The cell biology of the plasminogen system. FASEB J 1995; 9:939-945.